Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M55,801Revenue (TTM) $M20,708Net Margin (%)6.6Altman Z-Score3.5
Enterprise Value $M59,924EPS (TTM) $0.9Operating Margin %14.7Piotroski F-Score6
P/E(ttm)41.7Beneish M-Score-2.5Pre-tax Margin (%)6.6Higher ROA y-yN
Price/Book2.710-y EBITDA Growth Rate %-5.1Quick Ratio1.3Cash flow > EarningsY
Price/Sales2.75-y EBITDA Growth Rate %-7.7Current Ratio1.6Lower Leverage y-yN
Price/Free Cash Flow31.1y-y EBITDA Growth Rate %-35.1ROA % (ttm)3.4Higher Current Ratio y-yN
Dividend Yield %2.8PEG--ROE % (ttm)6.6Less Shares Outstanding y-yY
Payout Ratio %155Shares Outstanding M1,472ROIC % (ttm)72.3Gross Margin Increase y-yY

Gurus Latest Trades with ABT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABTFirst Eagle Investment 2016-09-30 Reduce-0.17%$39.44 - $45.29
($42.85)
$ 37.90-12%Reduce -57.24%1,271,914
ABTGeorge Soros 2016-09-30 Reduce-0.09%$39.44 - $45.29
($42.85)
$ 37.90-12%Reduce -21.26%259,181
ABTRichard Pzena 2016-09-30 Reduce-0.08%$39.44 - $45.29
($42.85)
$ 37.90-12%Reduce -5.81%5,017,660
ABTJoel Greenblatt 2016-09-30 Sold Out -0.06%$39.44 - $45.29
($42.85)
$ 37.90-12%Sold Out0
ABTMario Gabelli 2016-09-30 Add$39.44 - $45.29
($42.85)
$ 37.90-12%Add 0.07%13,695
ABTKen Fisher 2016-09-30 Add$39.44 - $45.29
($42.85)
$ 37.90-12%Add 0.39%12,435
ABTRobert Olstein 2016-06-30 Sold Out -1.23%$36.95 - $44.08
($39.84)
$ 37.90-5%Sold Out0
ABTFirst Eagle Investment 2016-06-30 Reduce-0.48%$36.95 - $44.08
($39.84)
$ 37.90-5%Reduce -60.38%2,974,455
ABTVanguard Health Care Fund 2016-06-30 Add0.38%$36.95 - $44.08
($39.84)
$ 37.90-5%Add 74.36%10,508,900
ABTJoel Greenblatt 2016-06-30 Reduce-0.34%$36.95 - $44.08
($39.84)
$ 37.90-5%Reduce -84.91%130,054
ABTRichard Pzena 2016-06-30 Add0.17%$36.95 - $44.08
($39.84)
$ 37.90-5%Add 14.76%5,327,448
ABTGeorge Soros 2016-06-30 Reduce-0.11%$36.95 - $44.08
($39.84)
$ 37.90-5%Reduce -21.47%329,181
ABTKen Fisher 2016-06-30 Reduce$36.95 - $44.08
($39.84)
$ 37.90-5%Reduce -19.63%12,387
ABTMario Gabelli 2016-06-30 Reduce$36.95 - $44.08
($39.84)
$ 37.90-5%Reduce -0.07%13,685
ABTJoel Greenblatt 2016-03-31 Add0.35%$36.34 - $44.91
($39.68)
$ 37.90-4%Add 771.99%861,862
ABTGeorge Soros 2016-03-31 Reduce-0.2%$36.34 - $44.91
($39.68)
$ 37.90-4%Reduce -36.89%419,181
ABTRobert Olstein 2016-03-31 Add0.11%$36.34 - $44.91
($39.68)
$ 37.90-4%Add 9.45%220,000
ABTFirst Eagle Investment 2016-03-31 Add0.09%$36.34 - $44.91
($39.68)
$ 37.90-4%Add 12.53%7,507,515
ABTRichard Pzena 2016-03-31 Reduce-0.06%$36.34 - $44.91
($39.68)
$ 37.90-4%Reduce -4.50%4,642,170
ABTKen Fisher 2016-03-31 Reduce$36.34 - $44.91
($39.68)
$ 37.90-4%Reduce -10.84%15,413
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABT is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
WHITE MILES DChairman and CEO 2016-11-10Buy58,263$40.67-6.81view
WHITE MILES DChairman and CEO 2016-11-10Buy48,761$40.65-6.77view
WHITE MILES DChairman and CEO 2016-11-10Buy89,578$40.53-6.49view
WHITE MILES DChairman and CEO 2016-11-10Buy121,456$40.45-6.3view
WHITE MILES DChairman and CEO 2016-11-10Buy51,892$40.54-6.51view
Blount Sally E.Director 2016-11-01Buy5,100$39.24-3.41view
Salvadori Daniel Gesua SiveSenior Vice President 2016-09-26Sell815$41.71-9.13view
Fussell Stephen RExecutive Vice President 2016-07-28Sell41,500$45-15.78view
Warmuth Michael JExecutive Vice President 2016-07-26Sell26,800$43.49-12.85view
Funck Robert EVice President, Controller 2016-07-25Sell26,800$43.08-12.02view

Quarterly/Annual Reports about ABT:

News about abt:

Articles On GuruFocus.com
Abbott's i-STAT Alinity Received CE Mark Nov 30 2016 
Medtronic Misses 2nd Quarter Revenue Expectations Nov 27 2016 
Abbott: $15 Billion Available From Notes Nov 25 2016 
Weak Outlook on Mylan Nov 18 2016 
Abbott Laboratories CEO Buys Stock in Company Nov 15 2016 
Abbott Labs: Absorb Heart Stent Approved in Japan Nov 07 2016 
Weekly Top Insider Buys Highlight for Week of November 4 Nov 05 2016 
Dividend Aristocrats in Focus Part 29: Abbott Laboratories Nov 03 2016 
Dividend Aristocrats in Focus Part 28: AbbVie Nov 03 2016 
AbbVie Reports 3rd Quarter Results Nov 01 2016 

More From Other Websites
MedTech Sails Through Macro Woes: Stocks in Focus Dec 02 2016
Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential Dec 01 2016
Abbott's i-STAT Alinity Received CE Mark Nov 30 2016
7:03 am Abbott Labs receives CE Mark for its i-STAT Alinity System Nov 30 2016
Abbott Announces CE Mark for i-STAT Alinity, a Pioneering, Handheld Blood Testing Platform Nov 30 2016
Is Time Warner Inc (TWX) Right for Your Portfolio? Nov 25 2016
Abbott: $15 Billion Available From Notes Nov 25 2016
J&J makes takeover approach for Swiss drugmaker Actelion - Bloomberg Nov 24 2016
The Smart Money’s Confidence in Abbott Laboratories (ABT) Continues to Rise Nov 23 2016
EU regulator conditionally approves Abbott's purchase of St Jude Nov 23 2016
Goldman Sachs' Most Meaningful Short Positions List Nov 23 2016
EU regulator conditionally approves Abbott's purchase of St Jude Nov 23 2016
ABBOTT LABORATORIES Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Nov 23 2016
[$$] Abbott Labs CEO Doubles His Stock Holdings Nov 23 2016
Massive Energy and Health Care Trades Highlight Insider Buying: Abbott Labs, Baker Hughes,... Nov 20 2016
ABBOTT LABORATORIES Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 17 2016
Abbott and Alere Need to Keep Talking Nov 17 2016
[$$] Abbott, St. Jude Medical to Sell $1.1 Billion in Assets Nov 17 2016
ABBOTT LABORATORIES Files SEC form 8-K, Change in Directors or Principal Officers Nov 16 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)